Literature DB >> 35760561

Proactive functional classification of all possible missense single-nucleotide variants in KCNQ4.

Honglan Zheng1,2,3, Xinhao Yan1,2,3, Guanluan Li1,2,3, Hengwei Lin1,2,3, Siqi Deng3, Wenhui Zhuang1,2,3, Fuqiang Yao1,2, Yu Lu4, Xin Xia1,2,3, Huijun Yuan4, Li Jin1, Zhiqiang Yan1,2,3.   

Abstract

Clinical exome sequencing has yielded extensive disease-related missense single-nucleotide variants (SNVs) of uncertain significance, leading to diagnostic uncertainty. KCNQ4 is one of the most commonly responsible genes for autosomal dominant nonsyndromic hearing loss. According to the gnomAD cohort, approximately one in 100 people harbors missense variants in KCNQ4 (missense variants with minor allele frequency > 0.1% were excluded), but most are of unknown consequence. To prospectively characterize the function of all 4085 possible missense SNVs of human KCNQ4, we recorded the whole-cell currents using the patch-clamp technique and categorized 1068 missense SNVs as loss of function, as well as 728 loss-of-function SNVs located in the transmembrane domains. Further, to mimic the heterozygous condition in Deafness nonsyndromic autosomal dominant 2 (DFNA2) patients caused by KCNQ4 variants, we coexpressed loss-of-function variants with wild-type KCNQ4 and found 516 variants showed impaired or only partially rescued heterogeneous channel function. Overall, our functional classification is highly concordant with the auditory phenotypes in Kcnq4 mutant mice and the assessments of pathogenicity in clinical variant interpretations. Taken together, our results provide strong functional evidence to support the pathogenicity classification of newly discovered KCNQ4 missense variants in clinical genetic testing.
© 2022 Zheng et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Year:  2022        PMID: 35760561      PMCID: PMC9435748          DOI: 10.1101/gr.276562.122

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.438


  55 in total

Review 1.  Neuronal KCNQ potassium channels: physiology and role in disease.

Authors:  T J Jentsch
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

Review 2.  Episodic disorders: channelopathies and beyond.

Authors:  Louis J Ptáček
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

3.  A Calmodulin C-Lobe Ca2+-Dependent Switch Governs Kv7 Channel Function.

Authors:  Aram Chang; Fayal Abderemane-Ali; Greg L Hura; Nathan D Rossen; Rachel E Gate; Daniel L Minor
Journal:  Neuron       Date:  2018-02-08       Impact factor: 17.173

4.  Annotating DNA variants is the next major goal for human genetics.

Authors:  Garry R Cutting
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

5.  A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression.

Authors:  Angeles Mencía; Daniel González-Nieto; Silvia Modamio-Høybjør; Ainhoa Etxeberría; Gracia Aránguez; Nieves Salvador; Ignacio Del Castillo; Alvaro Villarroel; Felipe Moreno; Luis Barrio; Miguel Angel Moreno-Pelayo
Journal:  Hum Genet       Date:  2007-11-21       Impact factor: 4.132

Review 6.  Epilepsy and developmental disorders: Next generation sequencing in the clinic.

Authors:  Joseph D Symonds; Amy McTague
Journal:  Eur J Paediatr Neurol       Date:  2019-12-18       Impact factor: 3.140

7.  Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.

Authors:  Francesco Miceli; Maria Virginia Soldovieri; Paolo Ambrosino; Michela De Maria; Michele Migliore; Rosanna Migliore; Maurizio Taglialatela
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

8.  KCNQ4: a gene for age-related hearing impairment?

Authors:  E Van Eyken; L Van Laer; E Fransen; V Topsakal; N Lemkens; W Laureys; N Nelissen; A Vandevelde; T Wienker; P Van De Heyning; G Van Camp
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

9.  ClinVar: public archive of interpretations of clinically relevant variants.

Authors:  Melissa J Landrum; Jennifer M Lee; Mark Benson; Garth Brown; Chen Chao; Shanmuga Chitipiralla; Baoshan Gu; Jennifer Hart; Douglas Hoffman; Jeffrey Hoover; Wonhee Jang; Kenneth Katz; Michael Ovetsky; George Riley; Amanjeev Sethi; Ray Tully; Ricardo Villamarin-Salomon; Wendy Rubinstein; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

10.  Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.

Authors:  Sarah E Brnich; Ahmad N Abou Tayoun; Fergus J Couch; Garry R Cutting; Marc S Greenblatt; Christopher D Heinen; Dona M Kanavy; Xi Luo; Shannon M McNulty; Lea M Starita; Sean V Tavtigian; Matt W Wright; Steven M Harrison; Leslie G Biesecker; Jonathan S Berg
Journal:  Genome Med       Date:  2019-12-31       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.